These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 18353413)
21. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique]. Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154 [TBL] [Abstract][Full Text] [Related]
22. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective. Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558 [TBL] [Abstract][Full Text] [Related]
23. Surface modified capillary electrophoresis combined with in solution isoelectric focusing and MALDI-TOF/TOF MS: a gel-free multidimensional electrophoresis approach for proteomic profiling--exemplified on human follicular fluid. Hanrieder J; Zuberovic A; Bergquist J J Chromatogr A; 2009 Apr; 1216(17):3621-8. PubMed ID: 19155017 [TBL] [Abstract][Full Text] [Related]
24. An overview of proteomic and metabolomic technologies and their application to pregnancy research. Horgan RP; Clancy OH; Myers JE; Baker PN BJOG; 2009 Jan; 116(2):173-81. PubMed ID: 19076949 [TBL] [Abstract][Full Text] [Related]
25. Proteomics, nanotechnology and molecular diagnostics. Johnson CJ; Zhukovsky N; Cass AE; Nagy JM Proteomics; 2008 Feb; 8(4):715-30. PubMed ID: 18297650 [TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of dog tears for potential cancer markers. de Freitas Campos C; Cole N; Van Dyk D; Walsh BJ; Diakos P; Almeida D; Torrecilhas A; Laus JL; Willcox MD Res Vet Sci; 2008 Oct; 85(2):349-52. PubMed ID: 18164356 [TBL] [Abstract][Full Text] [Related]
27. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research. Ekegren T; Hanrieder J; Bergquist J J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436 [TBL] [Abstract][Full Text] [Related]
28. Potential biomarkers of acute cerebral infarction detected by SELDI-TOF-MS. Zhang X; Guo T; Wang H; He W; Mei H; Hong M; Yu J; Hu Y; Song S Am J Clin Pathol; 2008 Aug; 130(2):299-304. PubMed ID: 18628101 [TBL] [Abstract][Full Text] [Related]
29. Proteomic identification of serum biomarkers for head and neck cancer surveillance. Gourin CG; Zhi W; Adam BL Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892 [TBL] [Abstract][Full Text] [Related]
30. Proteomic alteration in lung tissue of rats exposed to cigarette smoke. Zhang S; Xu N; Nie J; Dong L; Li J; Tong J Toxicol Lett; 2008 May; 178(3):191-6. PubMed ID: 18467043 [TBL] [Abstract][Full Text] [Related]
31. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling. Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507 [TBL] [Abstract][Full Text] [Related]
32. Identification of disease biomarkers by profiling of serum proteins using SELDI-TOF mass spectrometry. Langbein S Methods Mol Biol; 2008; 439():191-7. PubMed ID: 18370104 [TBL] [Abstract][Full Text] [Related]
33. Rapid analysis of proteomic biomarkers expressed in human endometrial stromal cells during decidualization. Oh KJ; Choi HJ; Yoon MS; Hwang JH; Chang SY; Kim YS; Han JS Arch Pharm Res; 2008 Oct; 31(10):1247-55. PubMed ID: 18958414 [TBL] [Abstract][Full Text] [Related]
34. Proteomic analysis of human breast cell lines using SELDI-TOF MS shows that mixtures of estrogenic compounds exhibit simple similar action (concentration additivity). Zhu Z; Edwards RJ; Boobis AR Toxicol Lett; 2008 Sep; 181(2):93-103. PubMed ID: 18675332 [TBL] [Abstract][Full Text] [Related]
35. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer. Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147 [TBL] [Abstract][Full Text] [Related]
36. Proteomic studies of early-stage and advanced ovarian cancer patients. Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221 [TBL] [Abstract][Full Text] [Related]
37. Development of proteomic signatures of platelet activation using surface-enhanced laser desorption/ionization technology in a clinical setting. Yin W; Czuchlewski D; Peerschke EI Am J Clin Pathol; 2008 Jun; 129(6):862-9. PubMed ID: 18480001 [TBL] [Abstract][Full Text] [Related]